http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107311986-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107311986-B |
| titleOfInvention | Tetrahydroisoquinoline-3-carboxylate heat shock protein 90 inhibitor and its application |
| abstract | The present invention discloses a tetrahydroisoquinoline-3-carboxylic acid type heat shock protein 90 inhibitor, the heat shock protein 90 inhibitor is a compound with general formula (I), or an optical isomer, non-pair An enantiomer or a racemate mixture thereof, or a pharmaceutically acceptable salt, solvate or prodrug thereof. The invention also discloses the application of the inhibitor in preparing a medicine for preventing or treating heat shock protein 90-related diseases. Experiments have confirmed that the tetrahydroisoquinoline-3-carboxylic acid heat shock protein 90 inhibitor of the present invention has a significant inhibitory effect on tumor cells derived from various tissue types including breast, reproductive and respiratory systems, but has a significant inhibitory effect on human normal liver cells. Low cytotoxicity and good druggability. It has broad prospects for clinical application. |
| priorityDate | 2017-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.